hyaluronidase / ocrelizumab Injection
RxNorm concept 2693455, clinical dose form (scdf).
- RxCUI
- 2693455
- Term type
- Clinical dose form (SCDF)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693455 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Injection (DF, has dose form)
- hyaluronidase (IN, has ingredient)
- ocrelizumab (IN, has ingredient)
- hyaluronidase / ocrelizumab Injection [Ocrevus Zunovo] (SBDF, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2693455 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693455 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2693455. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.